erythromycin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: erythromycin
Generic name: ERYTHROMYCIN
Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 1df12239-6957-4b2c-9e65-e2154eafddd0
SPL ID: c1d481ba-af9a-43d1-80ed-9db6109fe3ad
Version: 15
Effective date: 2023-02-04
Source export date: 2026-11-06
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/39f3c0903357a80632a5484c9d6a804272f4b297080aa9c5a01a84db133f7a03/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:59:15

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	062447	derived:openfda.application_number
application number		ANDA062447	openfda.application_number
brand name		erythromycin	openfda.brand_name
generic name		ERYTHROMYCIN	openfda.generic_name
manufacturer name		A-S Medication Solutions	openfda.manufacturer_name
ndc	package	50090-1958-0	openfda.package_ndc
ndc	product	50090-1958	openfda.product_ndc
ndc11	package	50090195800	derived:openfda.package_ndc
rxcui		310149	openfda.rxcui
spl id		c1d481ba-af9a-43d1-80ed-9db6109fe3ad	id
spl set id		1df12239-6957-4b2c-9e65-e2154eafddd0	set_id
unii		63937KV33D	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS: The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions. To report SUSPECTED ADVERSE REACTIONS, contact Perrigo at 1-866-634-9120 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.